CLASS II Device recall · Reported 4 Sep 2013 · FDA Enforcement Report

Accu-check FastClix Lancing Device recalled

Roche Diagnostics Operations is recalling Accu-check FastClix Lancing Device, distributed nationwide in the US. The recall was initiated on 19 Aug 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number(s): GDA 048, GDA050, GDA 051, GDA 063
Quantity recalled36,332

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2109-2013
FDA event ID
65886
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
19 Aug 2013
FDA classified
28 Aug 2013
Reported
4 Sep 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Processing Deviation

Timeline

19 Aug 2013Recall initiated by company
28 Aug 2013Classified by FDA+9 days
4 Sep 2013Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Internal Roche inspections have revealed that after the lancet is used for a finger stick, the needle may not fully retract back within the lancet drum or back into the cap. This allows the needle to protrude inside the cap or outside of the cap of the ACCU-CHEK FastClix lancing device.

The USDA issues these when meat or poultry was produced without proper inspection, or when a step such as cooking or pasteurisation did not meet requirements.

Product as listed by the FDA

ACCU-CHECK FastClix Lancing Device. It is intended for use in conjunction with a blood glucose monitoring system.

Where it was distributed

Nationwide Distribution

Nationwide

Questions about this recall

Is Accu-check FastClix Lancing Device recalled?

Yes. Roche Diagnostics Operations recalled Accu-check FastClix Lancing Device on 19 Aug 2013. The recall is Class II and its status is Terminated. Recall number Z-2109-2013.

Why was it recalled?

Internal Roche inspections have revealed that after the lancet is used for a finger stick, the needle may not fully retract back within the lancet drum or back into the cap. This allows the needle to protrude inside the cap or outside of the cap of the ACCU-CHEK FastClix lancing device.

Which lots are affected?

Lot Number(s): GDA 048, GDA050, GDA 051, GDA 063

Where was it sold?

Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Insulin Pumps & Glucose Monitors recalls

All 459